Non-mucosal vaccination strategies to enhance mucosal immunity
- PMID: 37881504
- PMCID: PMC10599649
- DOI: 10.18609/vac.2023.034
Non-mucosal vaccination strategies to enhance mucosal immunity
Abstract
The SARS-CoV-2 pandemic has highlighted the need for improved vaccines that can elicit long-lasting mucosal immunity. Although mucosal delivery of vaccines represents a plausible method to enhance mucosal immunity, recent studies utilizing intradermal vaccine delivery or incorporation of unique adjuvants suggest that mucosal immunity may be achieved by vaccination via non-mucosal routes. In this expert insight, we highlight emerging evidence from pre-clinical studies that warrant further mechanistic investigation to improve next-generation vaccines against mucosal pathogens, especially those with pandemic potential.
Conflict of interest statement
Morici LA discloses she has the following grants/contracts (HDTRA1–19-C0013; NIH 272201800045C; NIH/NIAID R01 AI166756–01). She receives consulting fees and payment for expert testimony from AP Experts LLC. McLachlan JB discloses he has the following grant/contract (NIH 01AI166756). Lastly, Tulane has an issued patent on vaccine adjuvant technology for which Morici LA and McLachlan JB are inventors.AUTHORSHIP & CONFLICT OF INTEREST
Similar articles
-
Intranasal delivery of an adenovirus-vector vaccine co-expressing a modified spike protein and a genetic adjuvant confers lasting mucosal immunity against SARS-CoV-2.Antiviral Res. 2023 Aug;216:105656. doi: 10.1016/j.antiviral.2023.105656. Epub 2023 Jun 14. Antiviral Res. 2023. PMID: 37327877 Free PMC article.
-
Adjuvants and delivery systems based on polymeric nanoparticles for mucosal vaccines.Int J Pharm. 2019 Dec 15;572:118731. doi: 10.1016/j.ijpharm.2019.118731. Epub 2019 Oct 24. Int J Pharm. 2019. PMID: 31669213 Review.
-
Mucosal vaccine design and delivery.Annu Rev Biomed Eng. 2012;14:17-46. doi: 10.1146/annurev-bioeng-071811-150054. Epub 2012 Apr 18. Annu Rev Biomed Eng. 2012. PMID: 22524387 Review.
-
Vaccines, adjuvants and key factors for mucosal immune response.Immunology. 2022 Oct;167(2):124-138. doi: 10.1111/imm.13526. Epub 2022 Jul 12. Immunology. 2022. PMID: 35751397 Review.
-
Mucosal adjuvants and delivery systems for protein-, DNA- and RNA-based vaccines.Immunol Cell Biol. 2004 Dec;82(6):617-27. doi: 10.1111/j.1440-1711.2004.01288.x. Immunol Cell Biol. 2004. PMID: 15550120 Review.
Cited by
-
Microbiome and Mucosal Immunity in the Intestinal Tract.In Vivo. 2025 Jan-Feb;39(1):17-24. doi: 10.21873/invivo.13801. In Vivo. 2025. PMID: 39740876 Free PMC article. Review.
References
-
- Liu L, Johnson HL, Cousens S, Perin J, et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet 2012; 379(9832), 2151–2161. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous